ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Medexus Pharmaceuticals Inc

Medexus Pharmaceuticals Inc (MDP)

7.75
0.00
(0.00%)
Closed 26 December 8:00AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
7.75
Bid
7.80
Offer
7.85
Volume
-
0.00 Day's Range 0.00
7.75 52 Week Range 7.75
Market Cap
Previous Close
7.75
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
24,458,000
Dividend Yield
-
PE Ratio
-373.56
Earnings Per Share (EPS)
-0.01
Revenue
113.05M
Net Profit
-214k

About Medexus Pharmaceuticals Inc

Sector
Pharmaceutical Preparations
Industry
Blank Checks
Website
Headquarters
Bolton, Gbr
Founded
2013
Medexus Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the TSX Venture Exchange with ticker MDP. The last closing price for Medexus Pharmaceuticals was $7.75. Over the last year, Medexus Pharmaceuticals shares have traded in a share price range of $ 7.75 to $ 7.75.

Medexus Pharmaceuticals currently has 24,458,000 shares in issue. The market capitalisation of Medexus Pharmaceuticals is $189.55 million. Medexus Pharmaceuticals has a price to earnings ratio (PE ratio) of -373.56.

MDP Latest News

Complete Response Letter Received from FDA for Treosulfan

TORONTO and CHICAGO and WEDEL, Germany, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF) and medac GmbH (“medac”) announced...

Medexus Appoints New Chief Financial Officer

TORONTO and CHICAGO, July 19, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF) is pleased to announce the appointment of Marcel Konrad...

Medexus Pharmaceuticals and medac GmbH enter into Licensing Agreement for First-in-Class Conditioning Agent, Treosulfan, in C...

TORONTO and CHICAGO and WEDEL, Germany, July 12, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSX: MDP) (OTCQX: MEDXF) today announced that it has entered...

Medexus Receives Notice of Compliance to Commercialize Treosulfan in Canada

TORONTO and CHICAGO, June 28, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSX: MDP) (OTCQX: MEDXF) today announced that it has received a Notice of...

Medexus Revenue Increases 43.5% to a Record US$79.7 Million for Fiscal 2021

Transformative licensing agreement for treosulfan in the U.S. completed February 2, 2021 Cash and cash equivalents of $18.7 million and available liquidity of $24.8 million at March 31, 2021...

Medexus Announces Graduation to the Toronto Stock Exchange

TORONTO and CHICAGO and MONTREAL, June 15, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSXV:MDP) (OTCQX: MEDXF) announced today that it has received final...

Medexus to Present at Raymond James Human Health Innovation Conference

TORONTO, CHICAGO and MONTREAL, June 14, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it...

Medexus Schedules Fiscal Year 2021 Conference Call

TORONTO and CHICAGO and MONTREAL, June 11, 2021 (GLOBE NEWSWIRE) -- , June 11, 2021 - Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) today...

Medexus Strengthens Medical Affairs Team in Preparation for Planned Treosulfan Launch

TORONTO, CHICAGO and MONTREAL, June 10, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) today announced that it...

Medexus Announces Availability of Triamcinolone Hexacetonide in the United States

TORONTO and CHICAGO and MONTREAL, June 09, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1007.757.757.7500CS
4007.757.757.7500CS
12007.757.757.7500CS
26007.757.757.7500CS
52007.757.757.7500CS
156007.757.757.7500CS
2603.93102.8795811523.829.751.4280696.80406428CS

MDP - Frequently Asked Questions (FAQ)

What is the current Medexus Pharmaceuticals share price?
The current share price of Medexus Pharmaceuticals is $ 7.75
How many Medexus Pharmaceuticals shares are in issue?
Medexus Pharmaceuticals has 24,458,000 shares in issue
What is the market cap of Medexus Pharmaceuticals?
The market capitalisation of Medexus Pharmaceuticals is CAD 189.55M
What is the 1 year trading range for Medexus Pharmaceuticals share price?
Medexus Pharmaceuticals has traded in the range of $ 7.75 to $ 7.75 during the past year
What is the PE ratio of Medexus Pharmaceuticals?
The price to earnings ratio of Medexus Pharmaceuticals is -373.56
What is the cash to sales ratio of Medexus Pharmaceuticals?
The cash to sales ratio of Medexus Pharmaceuticals is 0.7
What is the reporting currency for Medexus Pharmaceuticals?
Medexus Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Medexus Pharmaceuticals?
The latest annual turnover of Medexus Pharmaceuticals is USD 113.05M
What is the latest annual profit for Medexus Pharmaceuticals?
The latest annual profit of Medexus Pharmaceuticals is USD -214k
What is the registered address of Medexus Pharmaceuticals?
The registered address for Medexus Pharmaceuticals is 35 NIXON ROAD, UNIT 1, BOLTON, L7E 1K1
What is the Medexus Pharmaceuticals website address?
The website address for Medexus Pharmaceuticals is www.medexus.com
Which industry sector does Medexus Pharmaceuticals operate in?
Medexus Pharmaceuticals operates in the BLANK CHECKS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAAAAuralite Investments Inc
$ 0.265
(0.00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0.04
(0.00%)
0
AAAlba Minerals Ltd
$ 0.03
(0.00%)
0
A.HArmor Minerals Inc
$ 0.30
(0.00%)
0
AArmor Minerals Inc
$ 0.45
(0.00%)
0
AAAAAuralite Investments Inc
$ 0.265
(0.00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0.04
(0.00%)
0
AAAlba Minerals Ltd
$ 0.03
(0.00%)
0
A.HArmor Minerals Inc
$ 0.30
(0.00%)
0
AArmor Minerals Inc
$ 0.45
(0.00%)
0
AAAAAuralite Investments Inc
$ 0.265
(0.00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0.04
(0.00%)
0
AAAlba Minerals Ltd
$ 0.03
(0.00%)
0
A.HArmor Minerals Inc
$ 0.30
(0.00%)
0
AArmor Minerals Inc
$ 0.45
(0.00%)
0

Discussion

View Full Feed
SkeBallLarry SkeBallLarry 3 minutes ago
What Everyone Misses on Trump’s Panama Canal Pitch >

https://www.libertynation.com/what-everyone-misses-on-trumps-panama-canal-pitch/
SkeBallLarry SkeBallLarry 4 minutes ago
What Everyone Misses on Trump’s Panama Canal Pitch >

https://www.libertynation.com/what-everyone-misses-on-trumps-panama-canal-pitch/
SkeBallLarry SkeBallLarry 5 minutes ago
What Everyone Misses on Trump’s Panama Canal Pitch >

https://www.libertynation.com/what-everyone-misses-on-trumps-panama-canal-pitch/
Golden Cross Golden Cross 6 minutes ago
$ILLR Bouncing nicely off the bottom here... Think we get another nice rebound this time up to around the $4 area for starters...

https://investorshub.advfn.com/uimage/uploads/2024/12/26/xvmxnillr.png
ILLR
Golden Cross Golden Cross 6 minutes ago
$ILLR Bouncing nicely off the bottom here... Think we get another nice rebound this time up to around the $4 area for starters...

https://investorshub.advfn.com/uimage/uploads/2024/12/26/xvmxnillr.png
ILLR
europa7 europa7 7 minutes ago
Bitcoin price dips 4% as TradingView 'glitch' sends dominance to zero
"...BTC price stability wobbles in what appears to be a knee-jerk response to erroneous Bitcoin dominance data..."
26 December 2024
https://cointelegraph.com/news/bitcoin-price-dips-4-tradingview-glitch-domina
BTC
sharkey1 sharkey1 10 minutes ago
A BIG THX, The best news all year, WHOO HOO !!!!!!
ELTP
MartinLutherKing MartinLutherKing 10 minutes ago
Just spotted a pharma whale brother, buyout on open market
ELAB
KIPK KIPK 11 minutes ago
Karmic Slavery of Green Rotten Leaf on display 24/7....

As he posts "YAWN...nothing to see here" ...

KARMA has rooted... in, on, and under the rotten green leaf's
PHIL
longtermbeliever longtermbeliever 11 minutes ago
I expect the partnership announcement is around the corner.JUST HOLD ON TIGHT LOOOOOOOOOOOOOOOOONGS
AVXL
subslover subslover 12 minutes ago
SciSparc: AutoMax Announces $13 Million First Delivery of JAC Vehicles Following Regulatory Approval for Direct Importation
TEL AVIV, Israel, Dec. 26, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), announced that AutoMax Motors Ltd., (“AutoMax”), a leading au
SPRC
wickerman wickerman 13 minutes ago
$WNW nice pump and dump bravo to the bagholders.
WNW
Natural Trader Natural Trader 14 minutes ago
$LICN .30
LICN
Makai63 Makai63 15 minutes ago
News is out!!!
Elite Pharmaceuticals Announces Commercial Launch of Generic Vyvanse®
Northvale, New Jersey--(Newsfile Corp. - December 26, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic prod
ELTP
Konaploinks Konaploinks 16 minutes ago
I seriously doubt that our next court date in August was picked by our Judge arbitrarily. Think on that for awhile.
longtermbeliever longtermbeliever 16 minutes ago
our big pay day will come loongs.JUST HOLD ON TIGHT LOOOOOOOOOOOOOOOOONGS
AVXL
TheKid5 TheKid5 18 minutes ago
2025 will be our year
CLNV
longtermbeliever longtermbeliever 18 minutes ago
Only peer review is matter other papers just
a BS.JUST HOLD ON TIGHT LOOOOOOOOOOOOOOOOOOONGS
AVXL
flipper44 flipper44 19 minutes ago
Excellent Observation by XMaster!!! Many Thanks🙏

It confirms my thoughts that our patent application on Hyperactive Dendritic Cells directly/cooperatively draws from these studies.

By the way, as you know, “J.C.K” and “D.Z.” are lead authors
Jonathan
NWBO
jimmybob jimmybob 19 minutes ago
GM FOLKSSSSS
Konaploinks Konaploinks 20 minutes ago
Tempo Is the chit. Our competition is scrambling out from under delisting letters and trying to produce revenue other than grants ? All the while IonQ surges ahead . It looks like we’re all sitting pretty. Sit tight. Keep your eye on IonQ.
IONQ
trunkmonk trunkmonk 26 minutes ago
uh huh, Do clowns get up at 3:50am, spent a couple hours coming up with a phrase 3.5 limit, out of thin air? absolutely no substance whatsoever, one should just shut up and go back to bed and rethink their life instead of posting useless and baseless hate filled statements.
FNMA
penguin007 penguin007 27 minutes ago
Did not get coal, and did not get any gifts (yet) this year. It's all good, I feel good about giving, and that's what I did. $ZHUD 2025!
ZHUD
Southern Gal Southern Gal 28 minutes ago
How's that treasure on deck by EOY working out?
SFRX
exisnet exisnet 30 minutes ago
Confirmation will be a game changer...
BLTH